Midatech opens cGMP facility for production of nanoparticles
Midatech Group, a producer of nanoparticles for therapeutic and diagnostic applications, has opened its specialist design and manufacturing facility for cGMP grade nanoparticles in Bilbao, Spain. The company says Midatech Biogune SL is the world's first cGMP grade manufacturing plant for the production of nanoparticles at a scale commensurate with pharmaceutical applications.
Midatech Group, a producer of nanoparticles for therapeutic and diagnostic applications, has opened its specialist design and manufacturing facility for cGMP grade nanoparticles in Bilbao, Spain. The company says Midatech Biogune SL is the world's first cGMP grade manufacturing plant for the production of nanoparticles at a scale commensurate with pharmaceutical applications.
The plant will initially focus on the design and manufacture of nanoparticles to supply Midatech Group's series of projects applying nanotechnology for therapeutic purposes. These include using nanoparticles as scaffolds for synthetic vaccines and antibiotics, as drug delivery vehicles for RNAi drugs and drugs able to cross the blood brain barrier, as well as targeted cancer treatments and imaging agents.
The nanoparticles will allow drug companies to deliver new and existing medicines at significantly lower doses and with greater specificity, thereby reducing toxicity.
Speaking on the opening, md of Biogune, Justin Barry said: "We are delighted to launch the new facility in the dynamic environment of the Zamudio Science Park. We are very proud of the capabilities and future potential of the site, which represent a real step forward in realising the potential of nanoparticles for medical advancement.
Midatech's biocompatible nanoparticles possess a number of properties that make them ideal for therapeutics, diagnostics and other enabling applications.